Rosario Distefano

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 22

Top Venues

Signal transduction and targeted therapy

Cancers

Proceedings of the National Academy of Sciences of the United States of America

Cancer research

The Ohio State University

University of Verona (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

The Ohio State University Aug 21 2017

United States

Post-Doctoral Researcher :: Department of Cancer Biology and Genetics

Education History

University of Verona Jan 11 2014 - Jun 06 2017

Italy

PHD :: Computer Science

Publications

Gian Luca Rampioni Vinciguerra, Marina Capece, Luca Reggiani Bonetti, Giovanni Nigita, Federica Calore, Sydney Rentsch, Paolo Magistri, Roberto Ballarin, Fabrizio Di Benedetto, Rosario Distefano, Roberto Cirombella, Andrea Vecchione, Barbara Belletti, Gustavo Baldassarre, Francesca Lovat, Carlo M Croce
Nutrient restriction-activated Fra-2 promotes tumor progression via IGF1R in miR-15a downmodulated pancreatic ductal adenocarcinoma. Signal transduction and targeted therapy 9 (1) (2024)
Luisa Tomasello, Shoshanah M Holub, Giovanni Nigita, Rosario Distefano, Carlo M Croce
Poly(A)-specific RNase (PARN) generates and regulates miR-125a-5p 3'-isoforms, displaying an altered expression in breast cancer. Signal transduction and targeted therapy 9 (1) (2024)
Gian Luca Rampioni Vinciguerra, Marina Capece, Luca Reggiani Bonetti, Giovanni Nigita, Federica Calore, Sydney Rentsch, Paolo Magistri, Roberto Ballarin, Fabrizio Di Benedetto, Rosario Distefano, Roberto Cirombella, Andrea Vecchione, Barbara Belletti, Gustavo Baldassarre, Francesca Lovat, Carlo M Croce
Nutrient restriction-activated Fra-2 promotes tumor progression via IGF1R in miR-15a downmodulated pancreatic ductal adenocarcinoma. Signal transduction and targeted therapy 9 (1) (2024)
Luisa Tomasello, Shoshanah M Holub, Giovanni Nigita, Rosario Distefano, Carlo M Croce
Poly(A)-specific RNase (PARN) generates and regulates miR-125a-5p 3'-isoforms, displaying an altered expression in breast cancer. Signal transduction and targeted therapy 9 (1) (2024)
Gian Luca Rampioni Vinciguerra, Marina Capece, Luca Reggiani Bonetti, Giovanni Nigita, Federica Calore, Sydney Rentsch, Paolo Magistri, Roberto Ballarin, Fabrizio Di Benedetto, Rosario Distefano, Roberto Cirombella, Andrea Vecchione, Barbara Belletti, Gustavo Baldassarre, Francesca Lovat, Carlo M Croce
Nutrient restriction-activated Fra-2 promotes tumor progression via IGF1R in miR-15a downmodulated pancreatic ductal adenocarcinoma. Signal transduction and targeted therapy 9 (1) (2024)
Luisa Tomasello, Shoshanah M Holub, Giovanni Nigita, Rosario Distefano, Carlo M Croce
Poly(A)-specific RNase (PARN) generates and regulates miR-125a-5p 3'-isoforms, displaying an altered expression in breast cancer. Signal transduction and targeted therapy 9 (1) (2024)
Gian Luca Rampioni Vinciguerra, Marina Capece, Luca Reggiani Bonetti, Giovanni Nigita, Federica Calore, Sydney Rentsch, Paolo Magistri, Roberto Ballarin, Fabrizio Di Benedetto, Rosario Distefano, Roberto Cirombella, Andrea Vecchione, Barbara Belletti, Gustavo Baldassarre, Francesca Lovat, Carlo M Croce
Nutrient restriction-activated Fra-2 promotes tumor progression via IGF1R in miR-15a downmodulated pancreatic ductal adenocarcinoma. Signal transduction and targeted therapy 9 (1) (2024)
Luisa Tomasello, Shoshanah M Holub, Giovanni Nigita, Rosario Distefano, Carlo M Croce
Poly(A)-specific RNase (PARN) generates and regulates miR-125a-5p 3'-isoforms, displaying an altered expression in breast cancer. Signal transduction and targeted therapy 9 (1) (2024)
Gian Luca Rampioni Vinciguerra, Marina Capece, Rosario Distefano, Giovanni Nigita, Andrea Vecchione, Francesca Lovat, Carlo M Croce
Role of the miR-301a/Fra-2/GLIPR1 axis in lung cancer cisplatin resistance. Signal transduction and targeted therapy 8 (1) (2023)
Gian Luca Rampioni Vinciguerra, Marina Capece, Rosario Distefano, Giovanni Nigita, Andrea Vecchione, Francesca Lovat, Carlo M Croce
Role of the miR-301a/Fra-2/GLIPR1 axis in lung cancer cisplatin resistance. Signal transduction and targeted therapy 8 (1) (2023)
Gian Luca Rampioni Vinciguerra, Marina Capece, Rosario Distefano, Giovanni Nigita, Andrea Vecchione, Francesca Lovat, Carlo M Croce
Role of the miR-301a/Fra-2/GLIPR1 axis in lung cancer cisplatin resistance. Signal transduction and targeted therapy 8 (1) (2023)
Gian Luca Rampioni Vinciguerra, Marina Capece, Rosario Distefano, Giovanni Nigita, Andrea Vecchione, Francesca Lovat, Carlo M Croce
Role of the miR-301a/Fra-2/GLIPR1 axis in lung cancer cisplatin resistance. Signal transduction and targeted therapy 8 (1) (2023)
Gian Luca Rampioni Vinciguerra, Marina Capece, Rosario Distefano, Giovanni Nigita, Andrea Vecchione, Francesca Lovat, Carlo M Croce
Role of the miR-301a/Fra-2/GLIPR1 axis in lung cancer cisplatin resistance. Signal transduction and targeted therapy 8 (1) (2023)
Gian Luca Rampioni Vinciguerra, Marina Capece, Rosario Distefano, Giovanni Nigita, Andrea Vecchione, Francesca Lovat, Carlo M Croce
Role of the miR-301a/Fra-2/GLIPR1 axis in lung cancer cisplatin resistance. Signal transduction and targeted therapy 8 (1) (2023)
Rosario Distefano, Giovanni Nigita, Patricia Le, Giulia Romano, Mario Acunzo, Patrick Nana-Sinkam
Disparities in Lung Cancer: miRNA Isoform Characterization in Lung Adenocarcinoma. Cancers 14 (3) (2022)
Rosario Distefano, Luisa Tomasello, Gian Luca Rampioni Vinciguerra, Pierluigi Gasparini, Yujia Xiang, Marina Bagnoli, Gioacchino P Marceca, Paola Fadda, Alessandro Lagana, Mario Acunzo, Qin Ma, Giovanni Nigita, Carlo M Croce
Pan-Cancer Analysis of Canonical and Modified miRNAs Enhances the Resolution of the Functional miRNAome in Cancer. Cancer research 82 (20) (2022)
Tzung-Huei Lai, Hatice Gulcin Ozer, Pierluigi Gasparini, Giovanni Nigita, Rosario Distefano, Lianbo Yu, Janani Ravikrishnan, Ayse S Yilmaz, Juan Jesus Gallegos, Sachet A Shukla, Vinay K Puduvalli, Jennifer A Woyach, Rosa Lapalombella, James S Blachly, John C Byrd, Deepa Sampath
HDAC1 regulates the chromatin landscape to control transcriptional dependencies in chronic lymphocytic leukemia. Blood advances (2022)
Alessandro La Ferlita, Rosario Distefano, Salvatore Alaimo, Joal D Beane, Alfredo Ferro, Carlo M Croce, Philip N Tsichlis, Alfredo Pulvirenti, Giovanni Nigita
Transcriptome Analysis of Human Endogenous Retroviruses at Locus-Specific Resolution in Non-Small Cell Lung Cancer. Cancers 14 (18) (2022)
Gioacchino P Marceca, Luisa Tomasello, Rosario Distefano, Mario Acunzo, Carlo M Croce, Giovanni Nigita
Detecting and Characterizing A-To-I microRNA Editing in Cancer. Cancers 13 (7) (2021)
Masahisa Kudo, Nicole Zalles, Rosario Distefano, Giovanni Nigita, Dario Veneziano, Pierluigi Gasparini, Carlo M Croce
Synergistic apoptotic effect of miR-183-5p and Polo-Like kinase 1 inhibitor NMS-P937 in breast cancer cells. Cell death and differentiation (2021)
Francesca Lovat, Giovanni Nigita, Rosario Distefano, Tatsuya Nakamura, Pierluigi Gasparini, Luisa Tomasello, Paola Fadda, Narmin Ibrahimova, Silvia Catricalà, Alexey Palamarchuk, Michael A Caligiuri, Anna Gallì, Luca Malcovati, Mark D Minden, Carlo M Croce
Combined loss of function of two different loci of miR-15/16 drives the pathogenesis of acute myeloid leukemia. Proceedings of the National Academy of Sciences of the United States of America 117 (22) (2020)
Saleh Khawaled, Giovanni Nigita, Rosario Distefano, Sara Oster, Sung-Suk Suh, Yoav Smith, Abed Khalaileh, Yong Peng, Carlo M Croce, Tamar Geiger, Victoria L Seewaldt, Rami I Aqeilan
Pleiotropic tumor suppressor functions of WWOX antagonize metastasis. Signal transduction and targeted therapy 5 (1) (2020)

Rosario Distefano.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Rosario Distefano